Figure 5From: Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse Minimal residual disease (MRD) course of patient 2. The last examined sample was taken from peripheral blood (pb). Below the chromosomal break region with primers and hydrolysis probe indicated.Back to article page